Nasdaq smmt.

Oxford, UK, and Cambridge, MA, US, August 19, 2020 – Summit Therapeutics plc (NASDAQ: SMMT) today announces that at a Court convened meeting of shareholders and at a general meeting of ...OXFORD, United Kingdom, April 28, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular ...Summit Therapeutics Inc. Common Stock (SMMT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.SMMT Summit Therapeutics Inc Form PRE 14A - Other preliminary proxy statements. ... (NASDAQ:SMMT) Historical Stock Chart From Oct 2023 to Nov 2023 Summit Therapeutics (NASDAQ:SMMT)

LIESTAL, Switzerland, OXFORD, England and CAMBRIDGE, Mass., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Santhera Pharmaceuticals (SIX:SANN), Summit Therapeutics (NASDAQ:SMMT) (AIM:SUMM), Catabasis ...

Sarepta Ian Estepan: Tel: 617-274-4052 [email protected] W2O Group Brian Reid: Tel: 212-257-6725 [email protected]

Based on analysts offering 12 month price targets for SMMT in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . 26 de abr. de 2016 ... ... (NASDAQ: SMMT, AIM: SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy ('DMD') and ...Nov 28, 2023 · Stock analysis for Summit Therapeutics Inc (SMMT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Summit Therapeutics Plc operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company operates through the Drug Development segment, which covers its research and development activities carried out by the Group. Summit Therapeutics was founded by Stephen Graham Davies and ...The public float for SMMT is 111.77M and currently, short sellers hold a 8.48% ratio of that float. The average trading volume of SMMT on November 16, 2023 was 972.70K shares. SMMT) stock’s latest price update. The stock of Summit Therapeutics Inc (NASDAQ: SMMT) has increased by 0.51 when compared to last closing price of 1.97.

Sarepta Ian Estepan: Tel: 617-274-4052 [email protected] W2O Group Brian Reid: Tel: 212-257-6725 [email protected]

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s Major holders Insiders own 0.04% of the company shares, while shares held by institutions stand at 11.94% with a share float percentage of 11.95%. Investors are also buoyed by the number of investors in a company, with Tonix Pharmaceuticals Holding Corp having a total of 40 institutions that ...

Summit Therapeutics Inc. Common Stock (SMMT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Flotek Industries, Inc. (NYSE:FTK), OPKO Health, Inc. (NASDAQ:OPK), and Summit Therapeutics Inc. (NASDAQ:SMMT) are some penny stocks with insider buying. Click to continue reading and see 5 Penny ...Hedge fund interest in Summit Therapeutics PLC (NASDAQ:SMMT) shares was flat at the end of last quarter. This is usually a negative indicator. This is usually a negative indicator.Cambridge, Massachusetts, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced the postponement of its previously announced ...Webkoto_feja. Investment Summary. Following its recent thrust and breakout from 52-week lows, we are constructive on the mid-term outlook for Summit Therapeutics Inc (NASDAQ:SMMT).It's recent ...3 de fev. de 2023 ... Summit Therapeutics (NASDAQ:SMMT) shares are plummeting over 40% on Friday morning. Gaucho Group Holdings (NASDAQ:VINO) stock is diving more ...

Summit Therapeutics Inc (NASDAQ:SMMT) trade information. Instantly SMMT has showed a green trend with a performance of 0.50% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.12 on Friday, 11/03/23 increased the stock’s daily price by 5.19%.Summit Therapeutics Inc. (NASDAQ:SMMT) insiders placed bullish bets worth US$62m in the last 12 months. (Simply Wall St.) Mar-17-22 04:14PM. Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2021. (GlobeNewswire) +7.93%.Cambridge, MA, October 2, 2020 – Summit (NASDAQ: SMMT) today announces that it has entered into a binding agreement with the Company’s Chief Executive Officer and Executive Chairman, Robert W ...Summit Therapeutics (NASDAQ:SMMT) is a project of Bob Duggan of Pharmacyclics fame. This is what keeps our hopes in the future of this company alive, even though the company keeps changing so much ...Summit Therapeutics Inc (NASDAQ:SMMT) trade information. Instantly SMMT has showed a green trend with a performance of 0.50% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.12 on Friday, 11/03/23 increased the stock’s daily price by 5.19%.

Summit Therapeutics Inc. is traded on the NASDAQ under the ticker symbol "SMMT". What is Summit Therapeutics's primary industry? Company operates in the ...

Oxford, UK, and Cambridge, MA, US, 27 March 2019 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today reports its financial results for the ...Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced that the Company’s Board of Directors has set the record date for the Company’s previously announced rights offering, which will be available to all holders of record of the Company’s common stock, par value $0.01 (the “Common Stock”), as of the close of the market on February 6, 2023 (the ...OXFORD, United Kingdom, Oct. 04, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...Oxford, UK, and Cambridge, MA, US, 27 March 2019 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today reports its financial results for the ...Oxford, UK, and Cambridge, MA, US, 25 February 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, published preclinical data on SMT-571, a ...OXFORD, United Kingdom, Sept. 27, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...OXFORD, United Kingdom, Sept. 12, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...Fiscal Q3 2023 ended 9/30/23. Reported on 11/7/23. Get the latest Summit Therapeutics Inc (SMMT) real-time quote, historical performance, charts, and other financial information to …78% of the company is held by a single shareholder (Robert Duggan) Insiders have been buying lately. If you want to know who really controls Summit Therapeutics Inc. ( NASDAQ:SMMT ), then you'll ...OXFORD, United Kingdom, March 07, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) announces it has opened enrolment in a planned additional group in its Phase 2 open ...

Phunware Inc (NASDAQ:PHUN) has a beta value of 10.36 and has seen 4.58 million shares traded in the recent trading session. The company, currently valued at $19.34M, closed the recent trade at $0.14 per share which meant it gained $0.01 on the day or 13.69% during that session. The PHUN stock price ...Web

Jan 30, 2023 · MENLO PARK, Calif., January 30, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit" or the "Company") today announced that the Company’s Board of Directors has set the record date for the ...

Nov 8, 2023 · Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call. Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...WebFor the three months ended September 30th, 2018 vs September 30th, 2017, Global Payments reported revenue of $857.67MM vs $1,038.91MM (down 17.44%) and analysts estimated basic earnings per share ...WebNov 30, 2023 · The latest price target for Summit Therapeutics ( NASDAQ: SMMT) was reported by HC Wainwright & Co. on Wednesday, November 18, 2020. The analyst firm set a price target for 0.00 expecting SMMT to ... Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call. Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Cambridge, Massachusetts, and we have additional offices in Oxford, UK ...WebComplete Summit Therapeutics Inc. stock information by Barron's. View real-time SMMT stock price and news, along with industry-best analysis.Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK.Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Cambridge, Massachusetts, and we have additional offices in Oxford, UK ...Web

Oxford, UK, and Cambridge, MA, US, 9 July 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announces that it has demonstrated the potential of its DDS-04 series of new class ...The public float for SMMT is 111.75M, and currently, short sellers hold a 9.57% ratio of that floaft. The average trading volume of SMMT on November 08, 2023 was 1.02M shares. SMMT) stock’s latest price update. Summit Therapeutics Inc (NASDAQ: SMMT)’s stock price has plunge by -12.16relation to previous closing price of 2.18.Summit Therapeutics Inc NASDAQ: SMMT is a biopharmaceutical company focused on discovering, developing, and commercializing antibiotics for serious infectious ...Instagram:https://instagram. trade options td ameritradeeqx goldrefinance wells fargo home loan401k and ira contribution limits Oct 26, 2023 · MENLO PARK, Calif., October 26, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") will host an earnings call to announce its third quarter 2023 financial results and ... Dec 1, 2023 · Which Summit Therapeutics insiders have been buying company stock? The following insiders have purchased SMMT shares in the last 24 months: Ankur Dhingra ($217,390.39), Mahkam Zanganeh ($16,772,430.15), Manmeet Singh Soni ($4,999,999.20), and Robert W Duggan ($487,318,100.91). best florida flood insurancevspvx Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Cambridge, Massachusetts, and we have additional offices in Oxford, UK ... revology mustang Oxford, UK, and Cambridge, MA, US, 6 February 2020 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announced that it achieved the first milestone under its license and collaboration ...Summit Therapeutics Inc. (NASDAQ:SMMT) Short Interest Up 2,045.6% in December marketbeat.com - December 28 at 1:08 PM: Summit Therapeutics Inc.'s (NASDAQ:SMMT) CEO Robert Duggan is the most upbeat insider, and their holdings increased by 431% last week finance.yahoo.com - December 9 at 2:06 PM: marketbeat.com - December 9 at 10:28 AM